Liao Jia-Zhi, Zhao Qiu, Qin Hua, Li Rong-Xiang, Hou Wei, Li Pei-Yuan, Liu Nan-Zhi, Li De-Ming
Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Hepatobiliary Pancreat Dis Int. 2007 Feb;6(1):29-33.
Orthotopic liver transplantation has been widely used in patients with end-stage liver disease within the last two decades. However, the prevalence of biliary complications after liver transplantation remains high. The most common short-term biliary complication may be biliary leak. So, we examined 13 patients with biliary leak after liver transplantation, attempting to evaluate the role of endoscopic diagnosis and treatment of biliary leak and the incidence of bile duct stricture after healing of the leak.
Six cases of T-tube leak and seven cases of anastomosis leak complicating liver transplantation were enrolled in this prospective study. Six patients were treated by endoscopic plastic stent placement, two by nasobiliary catheter drainage, two by papillosphincterotomy, and three by nasobiliary catheter drainage combined with plastic stent placement. Some patients received growth hormone treatment.
The bile leak resolution time was 10-35 days in 10 patients with complete documentation. The median time of leak resolution was 15.3 days. Four cases of anastomosis stricture, three cases of common hepatic duct and one case of multiple bile duct stenosis were detected by follow-up nasobiliary catheter cholangiography or endoscopic retrograde cholangiopancreatography.
Endoscopic nasobiliary catheter or plastic stent placement is a safe and effective treatment for bile duct stricture occurring after bile leak resolution in most liver transplantation patients. Nasobiliary catheter combined with plastic stent placement may be the best choice for treating bile leak, because, theoretically, it may prevent the serious condition resulting from accidental nasobiliary catheter dislocation, and it may have prophylactic effects on upcoming bile duct stricture, although this should be further confirmed.
在过去二十年中,原位肝移植已广泛应用于终末期肝病患者。然而,肝移植后胆道并发症的发生率仍然很高。最常见的短期胆道并发症可能是胆漏。因此,我们对13例肝移植后胆漏患者进行了检查,试图评估内镜诊断和治疗胆漏的作用以及胆漏愈合后胆管狭窄的发生率。
本前瞻性研究纳入了6例肝移植合并T管漏和7例吻合口漏的患者。6例患者接受了内镜下塑料支架置入治疗,2例接受鼻胆管引流,2例接受乳头括约肌切开术,3例接受鼻胆管引流联合塑料支架置入。部分患者接受了生长激素治疗。
10例有完整记录的患者胆漏消退时间为10 - 35天。漏液消退的中位时间为15.3天。通过随访鼻胆管造影或内镜逆行胰胆管造影检测到4例吻合口狭窄、3例肝总管狭窄和1例多发胆管狭窄。
内镜下鼻胆管或塑料支架置入是大多数肝移植患者胆漏消退后发生胆管狭窄的一种安全有效的治疗方法。鼻胆管联合塑料支架置入可能是治疗胆漏的最佳选择,因为从理论上讲,它可以防止因鼻胆管意外移位导致的严重情况,并且可能对即将发生的胆管狭窄有预防作用,尽管这一点有待进一步证实。